Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
International Journal of Pharmaceutics|October 19, 2004
Process characterisation, optimisation and validation of production of diacetylmorphine/caffeine sachets: a design of experiments approachMarjolein G Klous, Bastiaan Nuijen, Wim Van den Brink, et al.
PDA Journal of Pharmaceutical Science and Technology|January 25, 2005
Pharmaceutical development of an intravenous dosage form of diacetylmorphine hydrochlorideMarjolein G Klous, Bastiaan Nuijen, Wim van den Brink, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 10, 2006
Anxiety and ethanol consumption in victorious and defeated mice; effect of kappa-opioid receptor activationNatalia Kudryavtseva, Mirjam A F M Gerrits, Damira F Avgustinovich, et al.
Drug and Alcohol Dependence|July 26, 2011
Craving and illicit heroin use among patients in heroin-assisted treatmentPeter Blanken, Vincent M Hendriks, Maarten W J Koeter, et al.
Clinical Pharmacokinetics|April 6, 2006
Population pharmacokinetics of heroin and its major metabolitesElisabeth J Rook, Alwin D R Huitema, Wim van den Brink, et al.
Behavioral Neuroscience|July 7, 2005
Neonatal amygdala lesions affect appetitive motivational and consummatory aspects of social behavior in the ratLeontien Diergaarde, Berry M Spruijt, Inge G Wolterink-Donselaar, et al.
Current Clinical Pharmacology|August 1, 2008
Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literatureElisabeth J Rook, Alwin D R Huitema, Wim van den Brink, et al.
Peptides|September 8, 2004
Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of miceNatalia N Kudryavtseva, Mirjam A F M Gerrits, Damira F Avgustinovich, et al.
Pageof 7